- Home
- AEMD vs PRFX Comparison
AEMD vs PRFX Comparison
Compare AEMD & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEMD | PRFX |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8M | 2.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | AEMD | PRFX |
|---|---|---|
| Price | $3.17 | $0.81 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $287.50 | N/A |
| AVG Volume (30 Days) | 70.4K | ★ 3.7M |
| Earning Date | 02-11-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.22 | $0.61 |
| 52 Week High | $64.00 | $6.65 |
Technical Indicators
Market Signals| Indicator | AEMD | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 45.33 |
| Support Level | $2.64 | $0.85 |
| Resistance Level | $3.19 | $1.59 |
| Average True Range (ATR) | 0.30 | 0.13 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 87.96 | 13.62 |
Price Performance
Historical ComparisonAbout AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.